Appropriate Use of Dual Antiplatelet Therapy.
作者信息
Wang Kang-Ling, Wang Tzung-Dau
机构信息
General Clinical Research Center, Taipei Veterans General Hospital.
School of Medicine, National Yang-Ming University.
出版信息
Acta Cardiol Sin. 2019 Jul;35(4):412-414. doi: 10.6515/ACS.201907_35(4).20190715A.
Abstract
摘要
相似文献
1
Appropriate Use of Dual Antiplatelet Therapy.双联抗血小板治疗的合理应用
Acta Cardiol Sin. 2019 Jul;35(4):412-414. doi: 10.6515/ACS.201907_35(4).20190715A.
2
Surgical tracheotomy performed with and without dual antiplatelet therapy.在接受和未接受双重抗血小板治疗的情况下进行手术气管切开术。
Open Med (Wars). 2014 Dec 29;10(1):101-105. doi: 10.1515/med-2015-0018. eCollection 2015.
3
When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet Therapy.当单一抗血小板药物预防卒中不足时：双重抗血小板治疗的当前证据与未来应用
Curr Treat Options Cardiovasc Med. 2016 Apr;18(4):26. doi: 10.1007/s11936-016-0449-7.
4
Experience using pipeline embolization device with Shield Technology in a patient lacking a full postoperative dual antiplatelet therapy regimen.在一名未进行完整术后双重抗血小板治疗方案的患者中使用带有屏蔽技术的管道栓塞装置的经验。
Interv Neuroradiol. 2018 Jun;24(3):270-273. doi: 10.1177/1591019917753824. Epub 2018 Jan 29.
5
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时三联抗血小板治疗与双联抗血小板治疗的比较
Circulation. 2009 Jun 30;119(25):3207-14. doi: 10.1161/CIRCULATIONAHA.108.822791. Epub 2009 Jun 15.
6
Systematic review of the clinical impact of dual antiplatelet therapy discontinuation after acute coronary syndromes.急性冠状动脉综合征后双联抗血小板治疗停药的临床影响的系统评价。
Eur Heart J Acute Cardiovasc Care. 2017 Sep;6(6):522-531. doi: 10.1177/2048872616648467. Epub 2016 May 3.
7
Dual antiplatelet therapy use by Canadian cardiac surgeons.加拿大心脏外科医生使用双重抗血小板治疗。
J Thorac Cardiovasc Surg. 2015 Dec;150(6):1548-54.e3. doi: 10.1016/j.jtcvs.2015.08.066. Epub 2015 Aug 28.
8
Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2.新一代药物洗脱支架植入术后6个月与12个月双重抗血小板治疗：ESTROFA-DAPT和ESTROFA-2的匹配分析
Rev Esp Cardiol (Engl Ed). 2015 Oct;68(10):838-45. doi: 10.1016/j.rec.2015.01.008. Epub 2015 Jun 11.
9
Systematic Review and Meta-analysis of Dual Versus Single Antiplatelet Therapy in Carotid Interventions.颈动脉介入治疗中双重抗血小板治疗与单一抗血小板治疗的系统评价和荟萃分析
Eur J Vasc Endovasc Surg. 2017 Jan;53(1):53-67. doi: 10.1016/j.ejvs.2016.10.011. Epub 2016 Nov 26.
10
Efficacy and safety of single versus dual antiplatelet therapy for coiling of unruptured aneurysms.未破裂动脉瘤弹簧圈栓塞术中单联与双联抗血小板治疗的疗效和安全性。
J Stroke Cerebrovasc Dis. 2013 Jul;22(5):650-5. doi: 10.1016/j.jstrokecerebrovasdis.2012.02.008. Epub 2012 Mar 21.
本文引用的文献
1
Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Bare Metal Stent Implantation: A Nationwide Cohort Study.氯吡格雷与质子泵抑制剂对2型糖尿病患者裸金属支架植入术后心血管事件的影响：一项全国性队列研究
Acta Cardiol Sin. 2019 Jul;35(4):402-411. doi: 10.6515/ACS.201907_35(4).20190108B.
2
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率：2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.
3
In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.基于证据的药物在医院内的应用与糖尿病急性冠脉综合征患者生存率的提高相关——来自TSOC ACS-DM注册研究的数据。
Acta Cardiol Sin. 2018 May;34(3):211-223. doi: 10.6515/ACS.201805_34(3).20180207B.
4
2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in Taiwan.《2018年台湾急性冠状动脉综合征抗血小板治疗不良反应管理专家共识》
Acta Cardiol Sin. 2018 May;34(3):201-210. doi: 10.6515/ACS.201805_34(3).20180302A.
5
The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.急性冠状动脉综合征的管理与预后因素：来自台湾急性冠状动脉综合征全谱注册研究的证据
Acta Cardiol Sin. 2017 Jul;33(4):329-338. doi: 10.6515/acs20161205a.
6
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.房颤患者 PCI 术后的达比加群双重抗血栓治疗。
N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.
7
The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension.台湾心脏病学会（TSOC）及台湾高血压学会（THS）2017年高血压管理指南重点更新版
Acta Cardiol Sin. 2017 May;33(3):213-225. doi: 10.6515/acs20170421a.
8
One-Year Outcomes of Acute Decompensated Systolic Heart Failure in Taiwan: Lessons from TSOC-HFrEF Registry.台湾急性失代偿性收缩性心力衰竭的一年结局：TSOC-HFrEF 注册研究的经验教训
Acta Cardiol Sin. 2017 Mar;33(2):127-138. doi: 10.6515/acs20170202a.
9
Deficiency of Endothelial Progenitor Cells Associates with Graft Thrombosis in Patients Undergoing Endovascular Therapy of Dysfunctional Dialysis Grafts.内皮祖细胞缺乏与功能失调的透析移植物血管内治疗患者的移植物血栓形成相关。
Acta Cardiol Sin. 2017 Jan;33(1):81-91. doi: 10.6515/acs20160225c.
10
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.经皮冠状动脉介入治疗（PCI）的房颤患者的出血预防。
N Engl J Med. 2016 Dec 22;375(25):2423-2434. doi: 10.1056/NEJMoa1611594. Epub 2016 Nov 14.
Zotero 插件